Objective To explore the optimal timing of postoperative review for different surgical diseases, and to improve the quality of operating room supervision and nursing care. Methods A total of 5 312 surgical patients who were operated from June to December 2015 were collected in the control group. 6 039 surgical patients who were operated from January to June 2016 were collected in the observation group. The control group followed the conventional operative visit time (i.e. three days after the operation) while the time for the observation group depended on different diseases. The postoperative visit time was 2-3 days for orthopedic surgery, 3-4 days for general or thoracic surgery, 5-6 days for brain surgery, and 0-1 day for special situations such as local anesthesia. The completeness of the collected data, detection rate of the positive event, and service satisfaction were compared between two groups. Results The observation group had significantly higher completeness of the review data, higher detection rate of the positive event, and better service satisfaction compared with the control group (P<0.05). Conclusions The timing of the postoperative visit should depend on different surgical diseases since the review data and feedback are more complete. It can improve the service satisfaction and the quality of feedback and nursing care.

AIM: To study effects and adverse drug reactions of mtrisone in the treatment of patients with severe acute respiratory syndrome. METHODS: The information of the medications in 680 patients with severe acute respiratory syndrome (SARS) in Xiaotangshan Hospital was collected by HIS system and the effects and ADRs of metrisone were staiated. RESULTS: The kinds of drugs of SARS patients who had been cured by metrisone were more than those which were not cured by metrisone. Condition of SARS patients who had been cured by metrisone was more serious than those which were not cured by metrisone. The ADRs rate, blood glucose and leukocyte of SARS patients who had been cured by metrisone are higher than those which were not cured by metrisone while blood K+ is lower. CONCLUSION: The utilization of metrison to SRAS patient should be more cautious to balance the effects and ADRs of metrisone.